PenumbraMEX:PEN 89 EBIT per Share is MXN94.85 as of Mar. 2026. GuruFocus rates MEX:PEN with a GF Score™ of 89/100 and a GF Value™ of MXN4,975.08. The stock has 1 warning sign investors should review. Among 690 Medical Devices & Instruments companies, Penumbra ranks better than 99.71% on this metric.
Penumbra's EBIT per Share for the
three
months ended in Mar. 2026 was MXN19.16.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN94.85.
During the past 12 months, the average EBIT per Share Growth Rate of Penumbra was 65.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 210.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Penumbra's EBIT per Share or its related term are showing as below:
MEX:PEN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -50.3 Med: 16.35 Max: 210.4
Current: 210.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Penumbra was 210.40% per year. The lowest was -50.30% per year. And the median was 16.35% per year.
MEX:PEN's 3-Year EBIT Growth Rate is ranked better than 99.71% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs MEX:PEN: 210.40
Penumbra's EBIT for the
three
months ended in Mar. 2026 was MXN757 Mil.
Penumbra (MEX:PEN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Penumbra EBIT per Share Related Terms
Penumbra EBIT per Share Historical Data
* Premium members only.
The historical data trend for Penumbra's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN94.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Penumbra (MEX:PEN) has a EBIT per Share of MXN94.85 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Penumbra and its competitors. According to the industry distribution chart, Penumbra ranks #2 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 0.3%.
Is Penumbra's EBIT per Share too high?
Penumbra's current EBIT per Share is MXN94.85. Based on the distribution chart, Penumbra ranks #2 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Penumbra has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's EBIT per Share compare to GMED and PODD?
According to the Medical Devices & Instruments industry distribution chart, Penumbra ranks #2 out of 690 companies for EBIT per Share. This places Penumbra in the top 0% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Penumbra and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Penumbra's current EBIT per Share is MXN94.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current EBIT per Share of MXN94.85. The stock's GF Value™ is MXN4,975.08, compared to a current price of MXN4,775.70 — trading 4% below its estimated fair value. The current EBIT per Share is MXN94.85. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current EBIT per Share is MXN94.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Penumbra (MEX:PEN) Overvalued in 2026?
Based on GuruFocus' analysis, Penumbra stock appears to be undervalued.
The current stock price of MXN4,775.70 is trading 4% below its estimated GF Value™ of MXN4,975.08.
Key valuation signals for MEX:PEN:
EBIT per Share: MXN94.85
GF Value™: MXN4,975.08 vs. price of MXN4,775.70 (4% below fair value)
No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score
Get the complete analysis for MEX:PEN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PEN has been successfully added to your 
